Slone Partners is active in the Clinical Trials / CRO space, providing counsel and delivering premier talent to the industry’s most innovative organizations. To stay on top of new market opportunities, trends, and challenges, we will attend the DIA conference this month.
DIA 2016, the largest global interdisciplinary health care event in the nation, will bring together over 7,000 thought leaders and innovators from the life sciences industry, academia, and government agencies. The DIA Conference has an incredible list of talks, tutorials, and networking sessions covering the clinical trials and CRO space. With so many valuable topics to choose from, we are providing you our list of Must See Talks at DIA 2016.
Monday, June 27 • 8:30am – 9:45am | Track: Reg Affairs
This session will give an opportunity to understand the requirements of the new European Clinical Trial Regulation, the IT developments for its implementation, and to discuss the expectations and preparedness for implementation by global sponsors. Speakers: Anabela Marcal, European Union, Marie-Agnes Heine, European Union, Elke Stahl, Federal Institute For Drugs and Medical Devices (BfArM), Nick Sykes, Pfizer Ltd.
Tuesday, June 28 • 8:00am – 9:30am | Track: DIAmond
“Alone we can do so little; together we can do so much.” Harnessing the power of collaboration truly has the ability to alter the healthcare landscape, as we know it today. What is the next generation of collaborations and what will be unique about them? What will change in our organizations in the future, and how will they be different from today? Speakers: Dalvir Gill, TransCelerate BioPharma Inc., Margaret Anderson, FasterCures, A Center of the Milken Institute, Christopher Austin, National Center for Advancing Translational Sciences, National Institutes of Health (NIH), Jonathan Jarow, Office of Medical Policy, CDER, FDA, C. David Nicholson, Brand R&D, Allergan, Drew Schiller, Validic
Tuesday, June 28 • 9:40am – 10:25am | Track: Engage and Exchange
Teams dominate the life science industry. High-functioning teams create a dynamic where innovation and productivity flourish; however, even the most motivated teams can have challenging team members or be derailed by uninformative feedback, critique, and criticism. Obtaining team buy-in and actionable feedback can be challenging. Speaker: Robin Whitsell, Whitsell Innovations, Inc.
Tuesday, June 28 • 10:30am – 11:45am | Track: Proj-Port Mgt-Strat Planning
This workshop will facilitate the participants’ examination of their own leadership behaviors and provide unique insight on how participants might develop new skills to expand their influence and impact. Get there early.Speaker: Richard Heaslip, Founder, Programmatic Sciences LLC
Tuesday, June 28 • 4:00pm – 5:15pm | Track: Innov Part Model-Outsourcing
The use of apps every day is a way of life, but in biopharmaceutical companies, teams struggle with how and when to use them. We will share DIY (build in house) and Amazon (off the shelf) case studies, their outcomes, and learnings. Speakers: Jane Myles, Genentech, A Member of the Roche Group, Joseph Kim, Eli Lilly and Company, James Kremidas, Association of Clinical Research Professionals (ACRP), Jeffrey Lee, mProve Health
Wednesday, June 29 • 8:00am – 9:30am | Track: DIAmond
Come hear from top thought-leaders about what innovations are in the pipeline that will both generate and harness BIG DATA. Learn how innovators will use Big Data to disrupt the health care system. This dynamic forward-focused session will bring together industry, technology innovators, academia, and government agencies to paint a colorful picture of how they will drive advances in health care founded on big data platforms. Speakers: Nancy Myers, Catalyst Healthcare Consulting, Inc, Amy Abernethy, Flatiron Health, Luciana Borio, Office of the Chief Scientist, OC, FDA, Kara Dennis, Medidata Solutions Worldwide, Michael Doherty, Foundation Medicine Inc., Hoffmann-La Roche Ltd., Sally Howard, Human Longevity, Inc.
Wednesday, June 29 • 10:30am – 11:45am | Track: Innov Part Model-Outsourcing
Outsourcing has been a major topic in the pharmaceutical industry over the last decade. As drug development costs increase, trial complexity grows and work in emerging markets becomes more important, the industry has looked toward outsourcing to help combat these challenges. Speakers: Scott Martin, KMR Group Inc., John Kurtz, Janssen R & D, LLC, Michael Minor, ICON Peri-Approval and Observational Research, Michael Williamson, UCB Biosciences, Inc.
8. Risky Business: Latest Trends, Strategies, and Tools for Predicting Success and Monitoring Risk During Clinical Trial Operations
Wednesday, June 29 • 2:00pm – 3:15pm | Track: Clinical Operations
This interactive session features a panel of leaders in pharmaceutical industry analytics who will describe the current data environment for clinical trial operations, lay out innovative metrics and related data sources, and help the audience map out a plan for implementing performance assessments that use all the data available to them. This frank exchange of ideas and practical experiences to weigh the trade-offs among various metrics and processes will have a particular emphasis on risk-based monitoring trends.Speakers: Angelique Hopkins, Bristol-Myers Squibb Company, Lucas Glass, IMS Health, Linda Sullivan, Metrics Champion Consortium LLC
Wednesday, June 29 • 4:00pm – 5:15pm | Track: Reg Affairs
Patients with unmet medical needs want early access to medicines. Regulators need to feel confident that the benefit-risk balance of a medicine they are licensing is positive. Regulators from the EU, Japan and the US will discuss how access to medicines can be speeded up and the use of post-marketing data to reduce the uncertainties. Speakers: Stella Blackburn, Quintiles Inc., Hans-Georg Eichler, European Union, Gerald Dal Pan, Office of Surveillance and Epidemiology, CDER, FDA, Toshiyoshi Tominaga, Pharmaceuticals and Medical Devices Agency (PMDA)
Thursday, June 30 • 10:45am – 12:00pm | Track: Innov Part Model-Outsourcing
With ever increasing rates of outsourcing and new models being created, pharmaceutical companies are seeking new ways to collaborate with CROs. Whether it is data, documents, team collaboration, etc., sponsors and CROs need easier ways to communicate. This session will discuss how to solve these challenges. Speakers: Matthew Kiernan, Pharmica, Jennifer Bush, Oracle Health Sciences, Lynn Fraser, BioClinica, Inc.
Download the DIA Global App
To learn more on how to bring on the best talent to your organization or to schedule a meeting at DIA 2016, please contact Slone Partners.
Related content: Clinical Trials Space Booming as DIA 2016 Approaches